CC&E: Oncology practices worry about start-up costs and disruption associated with adopting electronic medical records (EMRs). How does your company address these concerns?
DR. KHORSAND: We currently offer an extended trial period, so practices can pace themselves in learning the various aspects of the system. Although we have not yet released the pricing for Akessa Oncology, it will certainly be structured to fit the budget constraints of a solo practitioner as well as those of large size practices.
Because it was designed from the ground-up, working closely in cancer centers with clinicians and billing and management staff, our system closely mimics the real-life workflows of an oncology practice.
So rather than forcing an oncology practice to adapt to atypical, nononcology workflows, Akessa Oncology minimizes disruption by providing a practice with the ability to automate their existing business and clinical workflows, thereby cutting back on training time and costs, and speeding up the implementation phase.
Furthermore, during implementation, we leverage our open architecture to import data from existing systems to make the transition as seamless as possible.
CC&E: What feature of Akessa Oncology would you tout as something that sets your product apart from other systems?
DR. KHORSAND: We have an integrated system that introduces efficiencies by having oncology-specific billing, patient scheduling, EMR, and pharmaceutical inventory management modules all communicate with each other to deliver an optimal clinical and business management solution for oncology practices.
